19.17  -0.93 (-4.63%)		07-17 16:00
Open: 19.805 High: 20.07 Volume: 230,691		Pre. Close: 20.1 Low: 19.13 Market Cap: 5,233(M)

Short term
Mid term
Targets	6-month :	23.58	1-year :	27.55
Resists	First :	20.19	Second :	23.58
Pivot price	19.06
Supports	First :	17.76	Second :	16.27
MAs	MA(5) :	19.55	MA(20) :	18.64
	MA(100) :	16.64	MA(250) :	20.05
MACD	MACD :	0.5	Signal :	0.4
%K %D	K(14,3) :	74.2	D(3) :	78.9
RSI	RSI(14): 54.2
52-week	High :	27.89	Low :	12.84

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ STVN ] has closed below upper band by 46.5%. Bollinger Bands are 17.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	20.1 - 20.2	20.2 - 20.28
Low:	18.9 - 19.01	19.01 - 19.09
Close:	19.02 - 19.18	19.18 - 19.31

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

Sun, 19 Jul 2026
Roubaix Capital LLC Has $5.30 Million Holdings in Stevanato Group S.p.A. $STVN - MarketBeat

Sat, 18 Jul 2026
Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Fri, 17 Jul 2026
Stevanato Group SpA (STVN) Stock Down 4.6% -- Now Undervalued? G - GuruFocus

Mon, 13 Jul 2026
Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring A 24.81% Potential Upside - DirectorsTalk Interviews

Wed, 01 Jul 2026
TimesSquare Mid Cap Growth Strategy Downplays Market Fears on Stevanato Group S.p.A. (STVN) - Yahoo Finance

Fri, 26 Jun 2026
Luciano Santel receives 4,975 Stevanato (STVN) shares as director pay - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	50 (M)
Shares Float	49 (M)
Held by Insiders	1.6 (%)
Held by Institutions	97.5 (%)
Shares Short	946 (K)
Shares Short P.Month	1,010 (K)

EPS	0.57
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	6.38
Profit Margin	11.7 %
Operating Margin	14.2 %
Return on Assets (ttm)	5.2 %
Return on Equity (ttm)	9.5 %
Qtrly Rev. Growth	6.5 %
Gross Profit (p.s.)	7.07
Sales Per Share	24.14
EBITDA (p.s.)	5.8
Qtrly Earnings Growth	2.9 %
Operating Cash Flow	262 (M)
Levered Free Cash Flow	-57 (M)

PE Ratio	33.05
PEG Ratio	3.5
Price to Book value	3
Price to Sales	0.79
Price to Cash Flow	3.64

Dividend	0.05
Forward Dividend	0
Dividend Yield	0.3%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.